Protocol Services by Hurdle
The biggest health brands run structured programmes — intake, check-ins, monitoring, results, ongoing support. Hurdle gives you the same infrastructure, custom branded and clinically governed.
The platform behind your health programme.
Give your users a clinically governed health experience — from intake to outcomes — without building clinical infrastructure. Branded to you. Managed by us.
- Branded intake, onboarding, and digital check-ins
- At-home blood testing when your programme needs clinical data
- Plain-language results and ongoing support under your brand
- Clinical safety, governance, and priority-banded safety flag pathway built in
- Real-time dashboard and cohort reporting from day one
Examples shown are based on the UK service. Regional expansion capability is available — biomarker units, clinical language, and logistics can be localised for each market.
What have you done in the past to lose weight?
Baseline / treatment start · Week 0
Your baseline results. These will be used as the reference point for all future comparisons.
Next: Early response & titration review · Week 12
What have you done in the past to lose weight?
Baseline / treatment start · Week 0
Your baseline results. These will be used as the reference point for all future comparisons.
Next: Early response & titration review · Week 12
The platform
Live in days, not months.
Add a link to your site. Your first users can complete intake the same day. No engineering, no clinical build, no hiring.
Hurdle is a managed health pathway platform. We provide the clinical infrastructure to run a structured programme for your users — digital intake, structured check-ins, at-home blood testing, plain-language results, urgent-result communication pathways, and ongoing support. All custom branded. All clinically governed.
Go live fast
Add a link to your site and your users can start the same day. No engineering or clinical build required.
Branded to you
Intake, results, reminders — all custom branded. Your users see your brand, not ours.
Clinical safety included
Priority-banded safety flag pathway, governance rules, and audit trails are built into the service. No additional clinical-operations build is required from the partner.
See everything
Real-time dashboard from the first enrolment. Cohort health, individual status, protocol performance.
Configure, don't build
Activate the sub-protocols you need. Add or remove blood testing at any stage. Change it anytime.
Gets smarter over time
Aggregate programme analytics are reviewed periodically and may inform future protocol recommendations, subject to clinical governance review and version control.
How it connects
How it connects to your business.
You choose how users enter, what they're enrolled into, and what you see. We handle the orchestration, logistics, and clinical safety in between.
Integrate
Add a single link to your website, app, or email. Your users land on a custom-branded intake page — hosted by us, styled to your brand. Or embed it directly into your existing flow, or trigger it via email when a user signs up on your site.
Enrol
Your user completes a guided check-in — weight, symptoms, medical history. Their profile is created and the sub-protocols you've selected are activated automatically. You're notified the moment they're enrolled.
Monitor
Between stages, your users complete structured check-ins — weight, symptoms, and stage-specific questions. When blood testing is active, kits dispatch and return automatically. All data — self-reported and clinical — flows into one record you can see on your dashboard.
Communicate
Your users receive results in plain language on their phone — custom branded to your brand. Safety flags are routed through a four-tier priority pathway. Adherence prompts and follow-ups run automatically between stages. You stay informed without doing the work.
Report
Your dashboard shows real-time cohort health, individual user status, and protocol performance across your programme. As data accumulates, aggregate analytics may surface directional signals — subject to clinical governance review.
Sub-protocol library
Clinically governed sub-protocols, ready to activate.
Five clinically authored and clinically governed sub-protocols for Wegovy (semaglutide) weight management. Each includes a structured check-in. Blood testing can be activated at clinically defined stages.
Protocol authored by Hurdle's Head of Medical Affairs, March 2026. Version 2.2.
Pre-screening
OptionalBefore treatment starts
Capture health history and baseline data before treatment begins. Used when the programme wants objective blood data before prescribing review, or when recent clinically usable results are unavailable.
Structured intake questionnaire covering health history, medications, and contraindication screening.
Baseline
RecommendedWeek 0 — treatment start
Establish the longitudinal reference point at, or immediately before, treatment start. This becomes the anchor for all future trend reporting. Recent clinically usable results may be adopted as baseline if appropriate, to avoid unnecessary repeat sampling.
Captures weight and symptoms at the point treatment begins. Establishes the reference for all future comparisons.
Early response & titration
OptionalAround weeks 12–16
Meaningful early checkpoint for biological response and safety context during dose escalation; targeted renal or hepatobiliary review is added when symptoms, prior abnormalities, or clinician concern justify it.
Captures weight trend, side effects, and dose changes during the titration phase. Identifies users who may need clinical attention.
Ongoing monitoring
OptionalMonth 6, month 12, then tailored
Sustained monitoring across the treatment journey. Confirms continued improvement, identifies emerging safety concerns, and reinforces user engagement at common drop-off points.
Ongoing check-ins capture weight, symptoms, and medication adherence. Keeps users engaged at the points where drop-off is most common.
Clinical review / exception
OptionalAs clinically indicated
A clinician-directed exception pathway triggered by symptoms, safety flags, or clinical concern. It is not part of the routine scheduled programme and is used only when additional review or targeted follow-up is needed.
A symptom-triggered or clinician-requested check-in used when a concern has been identified. This is not a routine stage and is only activated when additional clinical review is needed.
8 markers available by indication
These are five examples from a growing library. Need something different? We build custom sub-protocols with you.
In practice
What it actually looks like.
Here's what happens at each touchpoint — what the user sees, what you see, and what's handled behind the scenes.
User is enrolled
Welcome to your health monitoring programme
Hurdle Health Monitoring
Welcome to your health monitoring programme
Over the next 12 months, you'll receive regular blood tests at home. Each stage is designed to monitor selected aspects of your health during treatment.
User appears in your cohort dashboard with status 'Enrolled'. Kit is dispatched automatically — no action needed from you.
Kit dispatched, tracking notification sent, preparation guidance included in-box and sent digitally. All written by the clinical team.
Results delivered in plain language
Your Results
HbA1c reflects your average blood sugar over the last 2 to 3 months. Your result is shown alongside the laboratory's reference information and will be used as part of your starting point for future comparison.
These results show your cholesterol pattern at the start of your programme. They help us understand your heart and metabolic health and give us a baseline to compare with future tests.
Part of your cholesterol results, needed to contextualise your overall lipid pattern and non-HDL cholesterol. One result on its own is only a snapshot — changes over time are often more helpful.
Part of the standard lipid profile, relevant to metabolic-risk context. Your result will be compared with future tests to track how your triglyceride pattern changes over time.
Non-HDL cholesterol is calculated from your standard cholesterol test. It gives a broader picture of the types of cholesterol linked with plaque build-up in the blood vessels. We report it as part of your overall cholesterol results.
LDL cholesterol is one part of your cholesterol results. It helps us build a clear starting picture at the beginning of the programme so that future results can be compared with it. It is most useful alongside your other cholesterol and triglyceride results.
ALT is a liver enzyme measured in the blood. It is included because liver health can be an important part of overall metabolic health. A result outside the reference range does not automatically mean there is a serious liver problem.
Status updates to 'Results ready'. If any marker is flagged, you see the alert priority level immediately.
Lab processes sample → results reviewed → user notified → partner notified → next stage scheduled. All automatic.
Safety flag raised
Health Alert
One or more of your results would be worth discussing with your prescriber or GP, especially if you have relevant symptoms, similar previous results or this test was added because of a specific clinical concern. This does not necessarily mean there is a serious problem, but it should not be ignored.
What to do
Contact your prescriber or GP practice within the next few days. You do not need to attend A&E or seek emergency care.
The responsible clinical service has been notified and will follow up as appropriate.
You receive an alert with the flag level (amber/orange/red) and affected marker. Operational messaging is handled by Hurdle; clinical follow-up is managed by the responsible clinical service — you have full visibility without any operational burden.
Flags generated automatically from clinical thresholds. Priority pathway determines urgency and routing. User contacted with clear, non-alarming guidance.
Collection kits
Everything they need, delivered to their door.
Users receive a complete blood collection kit by post. Kits are configured for the right tests at the right stage of treatment. Two collection options available.
How it works — 4 steps
Collect sample
Finger-prick or Tasso+ device — takes about 10 minutes
Label the tube
Attach the barcode label and seal in the specimen bag
Post it back
Place in the return box and drop in any Royal Mail postbox
Results in 48–72h
Plain-language results sent directly to the user
Collect sample
Finger-prick or Tasso+ device — takes about 10 minutes
Label the tube
Attach the barcode label and seal in the specimen bag
Post it back
Place in the return box and drop in any Royal Mail postbox
Results in 48–72h
Plain-language results sent directly to the user
Finger-prick collection kit
A capillary blood collection kit with lancets and illustrated step-by-step instructions. The user collects a small sample from their fingertip, labels it, seals it, and posts it back. Takes about 10 minutes.
- FDA cleared · CE marked · UKCA marked (where applicable to kit components)
- Collection tube + 3 lancets + alcohol wipes
- Illustrated 15-step instructions
- Specimen bag, security seal, pre-paid return
- Results in 48–72 hours from sample receipt
- ISO 15189 accredited laboratory processing
What's in the box
Tasso+ collection device
A push-button blood collection device applied to the upper arm. No lancet, no finger-prick. The Tasso+ device is FDA 510(k) cleared, CE marked, and UKCA marked (where applicable). Used by over 2 million users worldwide.
- Push-button — designed for minimal discomfort
- Upper arm collection — no finger-prick
- Tasso+ device: FDA cleared · CE marked · UKCA marked
- Designed for consistent sample volume
How to collect
- 1Activate heat pack, apply to upper arm for 4 mins
- 2Wipe area with alcohol wipe, allow to dry
- 3Attach tube to device, peel tab, remove cover
- 4Stick device to shoulder, press button firmly
- 5Wait for tube to fill between the lines
- 6Remove device, cap tube, label and return
Safety model
When results need follow-up
Results are interpreted alongside symptoms, history, medications, and earlier tests — not from the laboratory result alone. When follow-up is needed, the service assigns a priority band with clear next steps for the user and visibility for you. Results are assigned to a four-tier internal priority model based on predefined rules, symptom context, and review pathways. The colour band supports routing and response times; it does not replace clinical review where this is required.
| Priority band | User | Partner |
|---|---|---|
Routine | Your result set does not currently suggest that urgent follow-up is needed. We will use this as part of your baseline reference and compare it with future checks. | Dashboard shows all clear. Optional notification only if you opt in. |
Follow-up recommended | One or more results would be worth discussing with your prescriber or GP, especially if you have relevant symptoms, similar previous results or this test was added because of a specific clinical concern. This does not necessarily mean there is a serious problem, but it should not be ignored. | Amber alert. User notified. No urgent action required from you. |
Prompt clinical review advised | This result pattern should be reviewed promptly by a healthcare professional. Please contact your prescriber or GP practice as soon as possible. If you also have concerning symptoms, do not wait for your next routine check. | Orange result with affected biomarker: Urgent-result communication initiated in line with agreed clinical pathway; responsible clinical service notified. |
Urgent same-day help if symptoms are present | Routine blood testing is not appropriate if you have severe or persistent abdominal pain, repeated vomiting, yellowing of the skin or eyes, are having difficulty keeping fluids down, or you feel acutely unwell. Seek urgent medical advice the same day. If you cannot reach your usual clinician, use an urgent same-day service. | Red result with affected biomarker: Urgent-result communication initiated in line with agreed clinical pathway; responsible clinical service notified. |
Your result set does not currently suggest that urgent follow-up is needed. We will use this as part of your baseline reference and compare it with future checks.
Dashboard shows all clear. Optional notification only if you opt in.
One or more results would be worth discussing with your prescriber or GP, especially if you have relevant symptoms, similar previous results or this test was added because of a specific clinical concern. This does not necessarily mean there is a serious problem, but it should not be ignored.
Amber alert. User notified. No urgent action required from you.
This result pattern should be reviewed promptly by a healthcare professional. Please contact your prescriber or GP practice as soon as possible. If you also have concerning symptoms, do not wait for your next routine check.
Orange result with affected biomarker: Urgent-result communication initiated in line with agreed clinical pathway; responsible clinical service notified.
Routine blood testing is not appropriate if you have severe or persistent abdominal pain, repeated vomiting, yellowing of the skin or eyes, are having difficulty keeping fluids down, or you feel acutely unwell. Seek urgent medical advice the same day. If you cannot reach your usual clinician, use an urgent same-day service.
Red result with affected biomarker: Urgent-result communication initiated in line with agreed clinical pathway; responsible clinical service notified.
Important limitations
This blood test is one part of the overall assessment and should be interpreted alongside symptoms, current medicines, previous results, and clinical review. A home blood test cannot explain every symptom or replace medical assessment. It cannot diagnose all causes of severe abdominal pain, repeated vomiting, yellowing of the skin or eyes, dehydration, or feeling acutely unwell. If you have these symptoms, do not wait for routine testing or routine follow-up. Seek medical advice promptly, and seek urgent same-day help if symptoms are severe, persistent, or you are having difficulty keeping fluids down.
Partner dashboard
Full visibility. Zero operations.
You don't run any of this. But you see everything — which users are enrolled, where they are in the programme, and whether anyone needs attention.
What you do
- Enrol users into the programme
- View the partner dashboard
- Receive safety alerts
What we handle
- Kit dispatch & tracked delivery
- User preparation guidance
- Lab processing & quality control
- Results delivery in plain language
- Safety flag routing & user comms
- Scheduling of next stages
- Outcome reporting & evidence generation
Care programme overview
All users in one view. You see who's enrolled, where each one is in the programme, and whether any kits are in transit or results are pending.
Avg time in stage
10 weeks
Avg weight loss
3.2%
Expected duration
8–16 weeks (biomarker-driven)
Order status & tracking
Real-time kit dispatch and sample tracking. You see exactly where each user's kit is — from dispatch to lab receipt to results.
Safety alerts
When a user's results need attention, you see the flag level and affected marker immediately. Operational messaging is handled by Hurdle; clinical follow-up is managed by the responsible clinical service.
User C
ALT elevated — 52 U/L (ref: 10–49)
User notified. GP follow-up recommended.
Workflow automation
The intake questionnaire, kit dispatch triggers, and result notification workflows — all configured once, then fully automated. You set the rules; Hurdle runs them.
Weight Management Protocol — Automated pathway
Start Workflow
Trigger
Triage Questionnaire
12 questions
Email: Preparation guidance
Auto-send
Wait for submission
Up to 7 days
Determine kit type
Decision
Kit assignment branches
Care programme overview
All users in one view. You see who's enrolled, where each one is in the programme, and whether any kits are in transit or results are pending.
Avg time in stage
10 weeks
Avg weight loss
3.2%
Expected duration
8–16 weeks (biomarker-driven)
Order status & tracking
Real-time kit dispatch and sample tracking. You see exactly where each user's kit is — from dispatch to lab receipt to results.
Safety alerts
When a user's results need attention, you see the flag level and affected marker immediately. Operational messaging is handled by Hurdle; clinical follow-up is managed by the responsible clinical service.
User C
ALT elevated — 52 U/L (ref: 10–49)
User notified. GP follow-up recommended.
Workflow automation
The intake questionnaire, kit dispatch triggers, and result notification workflows — all configured once, then fully automated. You set the rules; Hurdle runs them.
Weight Management Protocol — Automated pathway
Start Workflow
Trigger
Triage Questionnaire
12 questions
Email: Preparation guidance
Auto-send
Wait for submission
Up to 7 days
Determine kit type
Decision
Kit assignment branches
Protocol intelligence
Ecosystem-wide outcomes. Data-driven protocol evolution.
Every partner running the protocol generates real-world outcome data. The aggregate is visible across all partners — performance by cohort, by region, by protocol variant. This data feeds back into protocol version updates, recommended to partners based on evidence from the collective.
Protocol analytics
Aggregate analytics may surface directional signals when observed differences emerge across protocol variants. Any recommendations are subject to clinical governance review and version control.
Outcome monitoring
Real-time aggregate outcomes across all partners: weight loss, adherence, persistence, and safety signals — tracked by protocol variant and region so patterns surface early.
Evidence generation
Structured evidence outputs in preparation from the collective dataset, subject to methodology review and appropriate governance.
Protocol analytics
Aggregate analytics may surface directional signals when observed differences emerge across protocol variants. Any recommendations are subject to clinical governance review and version control.
Outcome monitoring
Real-time aggregate outcomes across all partners: weight loss, adherence, persistence, and safety signals — tracked by protocol variant and region so patterns surface early.
Evidence generation
Structured evidence outputs in preparation from the collective dataset, subject to methodology review and appropriate governance.
Evidence Library
When aggregate data shows observed differences in outcomes, protocol analytics may surface directional signals — subject to clinical governance review before any protocol changes are recommended.
Performance across all partners running Protocol Services — aggregated, anonymised, updated quarterly.
Protocol analytics
Aggregate analytics may surface directional signals when observed differences emerge across protocol variants. Any recommendations are subject to clinical governance review and version control.
Outcome monitoring
Real-time aggregate outcomes across all partners: weight loss, adherence, persistence, and safety signals — tracked by protocol variant and region so patterns surface early.
Evidence generation
Structured evidence outputs in preparation from the collective dataset, subject to methodology review and appropriate governance.
Protocol analytics
Aggregate analytics may surface directional signals when observed differences emerge across protocol variants. Any recommendations are subject to clinical governance review and version control.
Outcome monitoring
Real-time aggregate outcomes across all partners: weight loss, adherence, persistence, and safety signals — tracked by protocol variant and region so patterns surface early.
Evidence generation
Structured evidence outputs in preparation from the collective dataset, subject to methodology review and appropriate governance.
Evidence Library
Data security & compliance
The safer way to handle health data.
Privacy and security are the foundations of the platform and built into every step. Hurdle has achieved and goes beyond all industry-leading security standards so you can be confident that sensitive health data is safe. Sample collection kits supplied through the pathway use CE marked and UKCA marked devices where applicable.
Responsibilities for the monitoring pathway are defined contractually, with Hurdle managing the agreed operational components and the responsible clinical service managing clinical decision-making and follow-up.
Access is role-based and limited to the partner, the user, Hurdle operational teams, laboratories, and agreed clinical services where required for the pathway.
Full control over data sharing within the agreed operating model.
Labs receive only anonymous barcodes and the minimum of personal information as required by law.
Testing performed in ISO 15189-accredited laboratories.
Results reviewed before release — anything outside expected ranges is flagged automatically.
All user-facing content written by a clinical team.
Compliance standards
Securely working with data from companies around the world.
Audited against AICPA Trust Services Principles for Security, Availability and Confidentiality.
Compliant for organisations that need to move PII data.
Certified commitment to securing all technology against cyber-attack.
Certified information security management system (ISMS).
Accredited requirements for certification bodies that audit management systems.
Medical devices — quality management systems for design, manufacture, and risk management.
EU In Vitro Diagnostic Medical Devices Regulation (2017/746) for applicable IVDs.
Securely working with data from companies around the world.
Audited against AICPA Trust Services Principles for Security, Availability and Confidentiality.
Compliant for organisations that need to move PII data.
Certified commitment to securing all technology against cyber-attack.
Certified information security management system (ISMS).
Accredited requirements for certification bodies that audit management systems.
Medical devices — quality management systems for design, manufacture, and risk management.
EU In Vitro Diagnostic Medical Devices Regulation (2017/746) for applicable IVDs.
Enterprise-grade data security
- Encryption everywhere — all data encrypted in transit and at rest (TLS 1.2+, AES-256).
- Identity and access management with multi-factor authentication.
- Regular point-in-time backups of all data.
- Complete segregation of environments.
- Access controlled based on least privilege and reviewed regularly.
Robust and secure software
- Regular penetration tests by independent third parties.
- Secure software development lifecycle with automated static code analysis and code review.
- Continuous vulnerability monitoring with clear remediation processes and SLAs.
Dedication to privacy
- Data processed in accordance with UK/EU GDPR and HIPAA, with consent where relevant and contractual/legal bases for permitted disclosures.
- Compliant to UK/EU GDPR and HIPAA.
- Processes in place for subject access requests — view, correct, delete, and port data.
- Data retention policies in place.
Resilience and availability
- Designed for high availability across multiple availability zones.
- 24×7 monitoring of availability, security and performance with on-call engineering.
- Continual incremental data backups.
- Disaster recovery and business continuity plan tested regularly.
Enterprise-grade data security
- Encryption everywhere — all data encrypted in transit and at rest (TLS 1.2+, AES-256).
- Identity and access management with multi-factor authentication.
- Regular point-in-time backups of all data.
- Complete segregation of environments.
- Access controlled based on least privilege and reviewed regularly.
Robust and secure software
- Regular penetration tests by independent third parties.
- Secure software development lifecycle with automated static code analysis and code review.
- Continuous vulnerability monitoring with clear remediation processes and SLAs.
Dedication to privacy
- Data processed in accordance with UK/EU GDPR and HIPAA, with consent where relevant and contractual/legal bases for permitted disclosures.
- Compliant to UK/EU GDPR and HIPAA.
- Processes in place for subject access requests — view, correct, delete, and port data.
- Data retention policies in place.
Resilience and availability
- Designed for high availability across multiple availability zones.
- 24×7 monitoring of availability, security and performance with on-call engineering.
- Continual incremental data backups.
- Disaster recovery and business continuity plan tested regularly.
Regional availability
Regional availability
The platform behind your health programme.
Clinically governed. Custom branded. Ready to integrate. Give your users the experience they expect — without building the infrastructure.
More protocols in the library
What happens next
Share this document with your team
We scope your cohort together — typically a 30-minute call
Go live in 4 weeks — we handle all onboarding
Share this document with your team
We scope your cohort together — typically a 30-minute call
Go live in 4 weeks — we handle all onboarding
No engineering work required from you.